beyond spring pharma stock
It had slid 27 in the six months through Tuesday. Shares of BeyondSpring BYSI -362 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational.
Beyondspring Stock Lack Of Transparency Creates Downside Risk Nasdaq Bysi Seeking Alpha
According to the issued ratings of 6 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 2 buy.
. The stock has a market cap of 4944 million a PE ratio of -077 and a beta of 104. BYSI stock are taking off on Wednesday following an important update regarding the firms lung cancer treatment. BYSI stock news and headlines to help you in your trading and investing decisions.
BeyondSpring Presents New Plinabulin Data At ESMO Congress In Chemotherapy-Induced Neutropenia. Is a clinical-stage global biopharmaceutical company. BYSI shares are down 3080 at 1586.
BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from. BeyondSpring now will take its case to the. Access the Nasdaqs Largest 100 non-financial companies in a Single Investment.
Beyond Spring Pharmaceuticals BYSI Stock had a HUGE run today after it was announced they had data showing their treatment could potentially be the next bi. Things are changing fast in the stock market but were staying focused on the future. Check out these 3 market-beating stocks.
Get the latest BeyondSpring Inc. The Company is focused on developing cancer therapies to improve clinical outcomes for patients. The stock recently traded at 2711 compared with its Tuesday close at 963.
The stock has a 50 day simple moving average of 148 and a 200 day simple moving. Ad See how Invesco QQQ ETF can fit into your portfolio. Shares of BeyondSpring NASDAQ.
Wide Range Of Investment Choices Including Options Futures and Forex.
Beyondspring Stock Lack Of Transparency Creates Downside Risk Nasdaq Bysi Seeking Alpha
Beyondspring Nasdaqcm Bysi Share Price News Analysis Simply Wall St
Beyondspring Nasdaqcm Bysi Share Price News Analysis Simply Wall St
1
Circling Back On Beyondspring Bysi Stock Seeking Alpha
Stock Overview Beyondspring
Beyondspring Presents New Data From Lead Asset On Neutropenia In Multiple Myeloma Patients
1
1
Pipeline Beyondspring
Pipeline Beyondspring
Stock Overview Beyondspring
Beyondspring Analyst Sees Little Trouble In Big China Nasdaq
Circling Back On Beyondspring Bysi Stock Seeking Alpha
Circling Back On Beyondspring Bysi Stock Seeking Alpha
Beyondspring Would Be A Great Buy Except For The Perennial Need For Cash And Ensuing Dilution Nasdaq Bysi Seeking Alpha
Pipeline Beyondspring
Beyondspring Stock Lack Of Transparency Creates Downside Risk Nasdaq Bysi Seeking Alpha
Fda